Pregnancy outcomes after prenatal exposure to echinacea: the Norwegian Mother and Child Cohort Study

被引:0
作者
K. Heitmann
G. C. Havnen
L. Holst
H. Nordeng
机构
[1] University of Bergen,Department of Global Public Health and Primary Care and Centre for Pharmacy, Faculty of Medicine and Dentistry
[2] Oslo University Hospital,Regional Medicines Information and Pharmacovigilance Centre (RELIS)
[3] University of Oslo,PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, School of Pharmacy
[4] Norwegian Institute of Public Health,Division of Mental Health
来源
European Journal of Clinical Pharmacology | 2016年 / 72卷
关键词
Echinacea; Pregnancy; Herbal medicine; MoBa;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:623 / 630
页数:7
相关论文
共 73 条
[1]  
Karsch-Volk M(2014)Echinacea for preventing and treating the common cold Cochrane Database Syst Rev 2 690-693
[2]  
Barrett B(2002)Herbal medicine use in parturients Anesth Analg 94 787-792
[3]  
Kiefer D(2009)The use and the user of herbal remedies during pregnancy J Altern Complement Med 15 371-380
[4]  
Bauer R(2004)Use of herbal drugs in pregnancy: a survey among 400 Norwegian women Pharmacoepidemiol Drug Saf 13 31-3143
[5]  
Ardjomand-Woelkart K(2014)Echinacea and elderberry—should they be used against upper respiratory tract infections during pregnancy? Front Pharmacol 5 3141-1150
[6]  
Linde K(2000)Pregnancy outcome following gestational exposure to echinacea: a prospective controlled study Arch Intern Med 160 1146-439
[7]  
Hepner DL(2006)Cohort profile: the Norwegian Mother and Child Cohort Study (MoBa) Int J Epidemiol 35 435-159
[8]  
Harnett M(2000)The Medical Birth Registry of Norway: epidemiological research and surveillance throughout 30 years Acta Obstet Gynecol Scand 79 151-19
[9]  
Segal S(2008)Use of herbal drugs during early pregnancy in relation to maternal characteristics and pregnancy outcome Pharmacoepidemiol Drug Saf 17 16-33
[10]  
Camann W(2010)Attitudes to use of herbal medicine during pregnancy (Holdninger til og bruk av urtemedisin i svangerskapet) Norsk Farmaceutisk Tidsskrift 118 26-357